Responses to online GSTM1 genetic test results among smokers related to patients with lung cancer: A pilot study

Cancer Epidemiology Biomarkers and Prevention

Volumn 18, Issue 7, 2009, Pages 1953-1961

  Sanderson, Saskia C ^a   O'Neill, Suzanne C ^b   White, Della Brown ^c   Bepler, Gerold ^d   Bastian, Lori ^e   Lipkus, Isaac M ^e   McBride, Colleen M ^c  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b GEORGETOWN UNIVERSITY   (United States)

^c NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^d H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^e DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTATHIONE TRANSFERASE M1; NICOTINE;

ADULT; ARTICLE; CANCER PATIENT; CANCER RISK; FEMALE; FOLLOW UP; GENETIC ANALYSIS; GENETIC RISK; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; NICOTINE REPLACEMENT THERAPY; ONLINE ANALYSIS; PATIENT COUNSELING; PILOT STUDY; PRIORITY JOURNAL; SELF HELP; SMOKING; SMOKING CESSATION; TELEPHONE;

ADULT; CARCINOMA, NON-SMALL-CELL LUNG; COUNSELING; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; GENOTYPE; GLUTATHIONE TRANSFERASE; HEALTH BEHAVIOR; HUMANS; INTERNET; LUNG NEOPLASMS; MALE; MIDDLE AGED; PILOT PROJECTS; QUESTIONNAIRES; RISK FACTORS; SMOKING; SMOKING CESSATION;

EID: 67650456215     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-08-0620     Document Type: Article

References (34)

1. American Lung Association. Lung cancer fact sheet 2008.
2. Cromwell J, Bartosch WJ, Fiore MC, Hasselblad V, Baker T; Agency for Health Care Policy and Research. Cost-effectiveness of the clinical practice recommendations in the AHCPR guideline for smoking cessation. JAMA 1997;278:1759-66.
3. Roddy E, Antoniak M, Britton J, Molyneux A, Lewis S. Barriers and motivators to gaining access to smoking cessation services amongst deprived smokers - a qualitative study. BMC Health Serv Res 2006;6:147.
4. Bize R, Burnand B, Mueller Y, Cornuz J. Effectiveness of biomedical risk assessment as an aid for smoking cessation: a systematic review. Tob Control 2007;16:151-6.
5. Feero WG, Guttmacher AE, Collins FS. The genome gets personal-almost. JAMA 2008;299:1351-2.
6. McWilliams JE, Sanderson BJ, Harris EL, Richert-Boe KE, Henner WD. Glutathione S-transferase M1 (GSTM1) deficiency and lung cancer risk. Cancer Epidemiol Biomarkers Prev1995;4:589-94.
7. Benhamou S, Lee WJ, Alexandrie AK, et al. Meta- and pooled analyses of the effects of glutathione S-transferase M1 polymorphisms and smoking on lung cancer risk. Carcinogenesis 2002;23:1343-50.
8. Audrain J, Boyd NR, Roth J, Main D, Caporaso NF, Lerman C. Genetic susceptibility testing in smoking-cessation treatment: oneyear outcomes of a randomized trial. Addict Behav1997;22:741-51.
9. Lerman C, Gold K, Audrain J, et al. Incorporating biomarkers of exposure and genetic susceptibility into smoking cessation treatment: effects on smoking-related cognitions, emotions, and behavior change. Health Psychol 1997;16:87-99.
10. McBride CM, Halabi S, Bepler G, et al. Maximizing the motivational impact of feedback of lung cancer susceptibility on smokers' desire to quit. J Health Commun 2000;5:229-41.
11. McBride CM, Bepler G, Lipkus IM, et al. Incorporating genetic susceptibility feedback into a smoking cessation program for African-American smokers with low income. Cancer Epidemiol Biomarkers Prev; 2002;11:521-8.
12. Hamajima N, Atsuta Y, Goto Y, Ito H. A pilot study on genotype announcement to induce smoking cessation by Japanese smokers. Asian Pac J Cancer Prev2004; 5:409-13.
13. Hamajima N, Suzuki K, Ito Y, Kondo T. Genotype announcement to Japanese smokers who attended a health checkup examination. J Epidemiol 2006;16:45-7.
14. Ito H, Matsuo K, Wakai K, et al. An intervention study of smoking cessation with feedback on genetic cancer susceptibility in Japan. Prev Med 2006;42:102-8.
15. Carpenter MJ, Strange C, Jones Y, et al. Does genetic testing result in behavioral health change? Changes in smoking behavior following testing for A-1 antitrypsin deficiency. Ann Behav Med; 2007;33:22-8.
16. Sanderson SC, Humphries SE, Hubbart C, Hughes E, Jarvis MJ, Wardle J. Psychological and behavioural impact of genetic testing smokers for lung cancer risk: a phase II exploratory trial. J Health Psychol 2008;13:481-94.
17. Wright A J, Weinman J, Marteau TM. The impact of learning of a genetic predisposition to nicotine dependence: an analogue study. Tob Control 2003;12:227-30.
18. Wright AJ, French DP, Weinman J, Marteau TM. Can genetic risk information enhance motivation for smoking cessation? An analogue study. Health Psychol 2006;25:740-52.
19. Sanderson SC, Michie S. Genetic testing for heart disease susceptibility: potential impact on motivation to quit smoking. Clin Genet 2007;71:501-10.
20. Wright AJ, Takeichi C, Whitwell SC, Hankins M, Marteau TM. The impact of genetic testing for Crohn's disease, risk magnitude and graphical format on motivation to stop smoking: an experimental analogue study. Clin Genet 2008;73:306-14.
21. Griffin RJ, Dunwoody S, Neuwirth K. Proposed model of the relationship of risk information seeking and processing to the development of preventive behaviors. Environ Res 1999;80:S230-45.
22. McBride CM, Emmons KM, Lipkus IM. Understanding the potential of teachable moments: the case of smoking cessation. Health Educ Res 2003;18:156-70.
23. Lipkus IM, McBride CM, Pollak KI, Lyna P, Bepler G. Interpretation of genetic risk feedback among African American smokers with low socioeconomic status. Health Psychol 2004;23:178-88.
24. O'Neill SC, White DB, Sanderson SC, et al. The feasibility of online genetic testing for lung cancer susceptibility: uptake of a web-based protocol and decision outcomes. Genet Med 2008;10:121-30.
25. Wenzel L, Glanz K, Lerman C. Stress, coping and health behavior. In: Glanz K, Rimer BK, Lewis FM, editors. Health behavior and health education: theory, research, and practice. San Francisco: Wiley Imprint; 2002. p. 210-39.
26. Petty RE, Cacioppo JT. The elaboration likelihood model of persuasion. In: Berkowitz L, editor. Advances in experimental social psychology. New York: Academic Press; 1986. p. 123-205.
27. Mussweiler T. Comparison processes in social judgment: mechanisms and consequences. Psychol Rev 2003;110:472-89.
28. Rogers RW. Cognitive and physiological processes in fear appeals and attitude change: a revised theory of protection motivation. In: Cacioppo JT, Petty RE, editors. Social psychophysiology: a sourcebook. New York: Guilford Press; 1983. p. 153-76.
29. Witte K, Allen M. A meta-analysis of fear appeals: implications for effective public health campaigns. Health Educ Behav 2000;27:591-615.
30. Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom KO. The Fagerstrom test for nicotine dependence: a revision of the Fagerstrom tolerance questionnaire. Br J Addict 1991;86:1119-27.
31. Cummings KM, Hyland A, Fix B, et al. Free nicotine patch giveaway program 12-month follow-up of participants. Am J Prev Med 2006;31:181-4.
32. Miller N, Frieden TR, Liu SY, et al. Effectiveness of a large-scale distribution programme of free nicotine patches: a prospective evaluation. Lancet 2005;365:1849-54.
33. Bauer JE, Carlin-Menter SM, Celestino PB, Hyland A, Cummings KM. Giving away free nicotine medications and a cigarette substitute (Better Quit) to promote calls to a quitline. J Public Health Manag Pract 2006;12:60-7.
34. Sanderson SC, Wardle J. Associations between anticipated reactions to genetic test results and interest in genetic testing: will self-selection reduce the potential for harm? Genet Test 2008;12:59-66.